Primary ChAdOx1 vaccination fails to reactivate pre-existing, cross-reactive T cells

被引：0
|
作者：
Henze, L. [1 ,2 ,3 ,4 ,5 ]
Braun, J. [1 ,2 ,3 ,4 ,5 ]
Meyer-Arndt, L. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Juerchott, K. [1 ,2 ,3 ,4 ,5 ]
Schlotz, M. [9 ,10 ]
Michel, J. [12 ]
Grossegesse, M. [12 ]
Mangold, M. [1 ,2 ,3 ,4 ,5 ]
Dingeldey, M. [1 ,2 ,3 ,4 ,5 ]
Kruse, B. [1 ,2 ,3 ,4 ,5 ]
Holenya, P. [13 ]
Mages, N. [1 ,2 ,3 ,4 ,5 ]
Reimer, U. [13 ]
Eckey, M. [13 ]
Timmermann, B. [14 ]
Klein, F. [9 ,10 ,15 ,16 ]
Nitsche, A. [11 ,12 ]
Giesecke-Thiel, C. [14 ]
Loyal, L. [1 ,2 ,3 ,4 ,5 ]
Thiel, A. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Tech Univ Berlin, Si M Simulierte Mensch Sci Framework, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Free Univ Berlin, Berlin, Germany
[4] Humboldt Univ, Berlin, Germany
[5] Berlin Inst Hlth, Regenerat Immunol & Aging, BIH Immun, Berlin, Germany
[6] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany
[7] Berlin Inst Hlth, Berlin, Germany
[8] Charite Univ Med Berlin, Dept Neurol Expt Neurol, Berlin, Germany
[9] Univ Cologne, Expt Immunol Lab, Fac Med, Inst Virol, Cologne, Germany
[10] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[11] Robert Koch Inst, Highly Pathogen Viruses, Ctr Biol Threats & Special Pathogens, WHO Reference Lab SARS CoV, Berlin, Germany
[12] Robert Koch Inst, WHO Collaborating Ctr Emerging Infect & Biol Thre, Berlin, Germany
[13] JPT Peptide Technol GmbH, Berlin, Germany
[14] Max Planck Inst Mol Genet, Berlin, Germany
[15] German Ctr Infect Res DZIF, Partnersite Bonn Cologne, Cologne, Germany
[16] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P69
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [21] ChAdOx1 nCoV-19 vaccination generates spike-specific CD8+ T cells in aged mice
    Foster, William S.
    Newman, Joseph
    Thakur, Nazia
    Spencer, Alexandra J.
    Davies, Sophie
    Woods, Danielle
    Godfrey, Leila
    Ross, Sarah H.
    Sharpe, Hayley J.
    Richard, Arianne C.
    Bailey, Dalan
    Lambe, Teresa
    Linterman, Michelle A.
    IMMUNOLOGY AND CELL BIOLOGY, 2023, 101 (06): : 479 - 488
  • [22] Short Report: Pre-Existing Cross-Reactive Antibodies to Avian Influenza H5N1 and 2009 Pandemic H1N1 in US Military Personnel
    Pichyangkul, Sathit
    Krasaesub, Somporn
    Jongkaewwattana, Anan
    Thitithanyanont, Arunee
    Wiboon-ut, Suwimon
    Yongvanitchit, Kosol
    Limsalakpetch, Amporn
    Kum-Arb, Utaiwan
    Mongkolsirichaikul, Duangrat
    Khemnu, Nuanpan
    Mahanonda, Rangsini
    Garcia, Jean-Michel
    Mason, Carl J.
    Walsh, Douglas S.
    Saunders, David L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2014, 90 (01): : 149 - 152
  • [23] Vaccination preserves pre-existing memory CD4 T-cells during acute SIV infection
    Mattapallil, Joseph
    Douek, Daniel
    Buckler-White, Alicia
    Martin, Malcolm
    Montefiori, David
    Letvin, Norman
    Nabel, Gary
    Roederer, Mario
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S90 - S90
  • [24] Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination
    Mohn, Kristin G. I.
    Zhou, Fan
    Brokstad, Karl A.
    Sridhar, Saranya
    Cox, Rebecca J.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (10): : 1527 - 1535
  • [25] Immune responses of lung transplant recipients against SARS-CoV-2 and common respiratory coronaviruses: Evidence for pre-existing cross-reactive immunity
    Bansal, Sandhya
    Fleming, Timothy
    Canez, Jesse
    Maine, Gabriel N.
    Bharat, Ankit
    Walia, Rajat
    Tokman, Sofya
    Smith, Michael A.
    Tiffany, Brian
    Bremner, Ross M.
    Mohanakumar, T.
    TRANSPLANT IMMUNOLOGY, 2023, 81
  • [26] Antigenic Evolution on a Global Scale Reveals the Potential Natural Selection of Severe Acute Respiratory Syndrome-Coronavirus 2 by Pre-existing Cross-Reactive T-Cell Immunity
    Zhang, Chengdong
    Jin, Xuanxuan
    Chen, Xianyang
    Qiu, Li
    Leng, Qibin
    Qiu, Tianyi
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [27] Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children
    Li, Nina
    Li, XueYun
    Wu, Jiani
    Zhang, Shengze
    Zhu, Lin
    Chen, Qiqi
    Fan, Ying
    Wu, Zhengyu
    Xie, Sidian
    Chen, Qi
    Wang, Ning
    Wu, Nan
    Luo, Chuming
    Shu, Yuelong
    Luo, Huanle
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies
    Nziza, Nadege
    Jung, Wonyeong
    Mendu, Maanasa
    Chen, Tina
    Julg, Boris
    Graham, Barney
    Ramilo, Octavio
    Mejias, Asuncion
    Alter, Galit
    IMMUNITY, 2024, 57 (07) : 1681 - 1695.e4
  • [29] Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86
    Sette, Alessandro
    Sidney, John
    Grifoni, Alba
    CELL HOST & MICROBE, 2024, 32 (01) : 19 - 24.e2
  • [30] Cross-reactive T cells to pandemic influenza H1N1 are predominantly of an effector phenotype
    Sridhar, S.
    Begom, S.
    Bermingham, A.
    Bremang, S.
    Magtoto, M.
    Grass, L.
    Potiphar, L.
    Openshaw, P.
    Lalvani, A.
    IMMUNOLOGY, 2010, 131 : 176 - 176
12345